Remove topic contract-analytical-services
article thumbnail

Forge Biologics and Labcorp partner for gene therapies development

Pharmaceutical Technology

Gene therapy clients will gain access to coordinated scientific expertise, drug development services and AAV manufacturing capabilities, advancing the development of new gene therapies. This will improve accessibility to services for AAV-mediated gene therapy programmes.

article thumbnail

Four key considerations when shifting from fee-for-service to value-based arrangements

Clarify Health

She has many years of experience in value-based payment models, healthcare policy, contract negotiations and healthcare analytics. Shifting from fee for service to value has been a popular topic over the last 15-plus years, but progress has been slow. I am passionate about optimizing the success of value-based contracts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AGC and RoosterBio partner for cell and exosome therapy manufacturing

Pharmaceutical Technology

Biopharmaceutical contract development and manufacturing organisation (CDMO) AGC Biologics has entered a strategic collaboration with RoosterBio to expedite the manufacturing of cell and exosome therapies. Topic sponsors are not involved in the creation of editorial content.

article thumbnail

Four key considerations when shifting from fee-for-service to value-based arrangements

Clarify Health

She has many years of experience in value-based payment models, healthcare policy, contract negotiations and healthcare analytics. Video transcript: Shifting from fee for service to value has been a popular topic over the last 15-plus years, but progress has been slow. So why the hesitation?

article thumbnail

3 Ways to Engage Providers in Value-Based Care

Clarify Health

Malia Read, Vice President of Provider Performance Management of Anthem, and Lisa White, Director of Value-Based Partner Transformation at Horizon Blue Cross Blue Shield of New Jersey, joined me to discuss how to encourage providers to engage in value-based care — through contracting, design, management, technology, and more. Malia Read.

article thumbnail

Webinar Recap: John Muir Health Talks Data-Driven Strategies for Growth

Clarify Health

New volume growth, patient retention, and service line expansion are key levers of focus. Growing volume and expanding service lines don’t guarantee success, though. Prior to working with Clarify, one of the challenges JMH encountered using external analytics resources was particularly in smaller geographic segments.

article thumbnail

Webinar Recap: John Muir Health Talks Data-Driven Strategies for Growth

Clarify Health

New volume growth, patient retention, and service line expansion are key levers of focus. Growing volume and expanding service lines don’t guarantee success, though. Prior to working with Clarify, one of the challenges JMH encountered using external analytics resources was particularly in smaller geographic segments.